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 Abstract 
 A 25-year-old otherwise healthy male presented with new-onset odynophagia, rash, and oro-
genital ulcers. Despite treatment with antibiotics for presumed bacterial pharyngitis, the pa-
tient remained symptomatic, with abnormal vital signs and laboratory values. Upon dermatol-
ogy consultation and histopathologic correlation, he was diagnosed with Behçet disease. 
Behçet disease is a rare rheumatologic condition that presents with recurrent oral ulcers and 
varying degrees of ophthalmic, neurologic, cardiac, and vascular disease. Given its protean 
nature, the treatment of Behçet disease is tailored to the patient’s presentation and severity 
of organ involvement. Following treatment with colchicine and prednisone, the patient’s 
symptoms improved rapidly. 
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 Case Report 
 A 25-year-old male with no past medical history presented with odynophagia, new rash, 
and orogenital ulcerations. Shortly after labral repair of the right hip 18 days prior to 
admission, the patient developed pharyngitis, odynophagia, fevers, chills, and night sweats. 
He was treated with amoxicillin for a presumed bacterial pharyngitis by his primary care 
physician who noted anterior cervical lymphadenopathy, tonsillar enlargement, and erythema 
on examination. At that time, he also noted headaches, myalgias in his bilateral thighs and 
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calves, as well as a recent weight loss of approximately 7–8 pounds. Despite treatment with 
amoxicillin, the patient remained febrile with ongoing pharyngitis and was seen again by his 
primary care physician; he was switched to amoxicillin-clavulanate. Heterophile antibodies 
were negative and liver and renal function tests were within normal limits. He subsequently 
developed oral and genital ulcers, worsening odynophagia, and a pustular rash on his face, 
trunk, and limbs, prompting admission.
 He was admitted to hospital and treated with ampicillin-sulbactam and acyclovir as well 
as with hydromorphone, acetaminophen, ibuprofen, and morphine to control his oral pain. 
On examination, temperature was 37.1 ° C. Cutaneous examination was notable for scattered 
intact pustules and papules with collarets of scale on the face, trunk, and extremities ( Fig. 1 a) 
along with tender erythematous nodules on the bilateral shins. Orogenital examination 
revealed grouped clean-based ulcerations on the vermillion lips and soft palate, erythem-
atous clustered erosions on the tonsils ( Fig. 1 b), and clean-based ulcers on the scrotum and 
glans penis. Of note, there was no involvement of the palms or soles. Three-millimeter punch 
biopsies were performed on the lower lip and shoulder.
 Initial laboratory studies were notable for leukocytosis (21,000/mm 3 with 82% poly-
morphonuclear leukocytes) and elevated C-reactive protein (236 mg/L), erythrocyte sedi-
mentation rate (90 mm/h), and ferritin (481 ng/mL). Rapid strep, human immunodeficiency 
virus, and heterophile antibody tests were all negative. A viral polymerase chain reaction of 
the patient’s penis/lip ulcers were negative for herpes simplex virus, blood cultures demon-
strated no growth, and wound culture of a pustule on his shoulder was also negative for 
microorganisms.
 Histopathologic examination of the lower lip revealed an ulcerated squamous epithelium 
with underlying dense infiltrate of neutrophils, histiocytes, and lymphocytes ( Fig. 2 a). 
Fibrinoid necrosis of the walls of the small vessels and perivascular and interstitial infiltrate 
of neutrophils, histiocytes, and lymphocytes were noted, all supportive of small-vessel vascu-
litis ( Fig. 2 b). The biopsy from the shoulder demonstrated acute folliculitis and focal adjacent 
small-vessel vasculitis with associated karyorrhectic debris.
 These histopathologic findings in conjunction with the patient’s orogenital ulcerations, 
papulopustular eruption, likely erythema nodosum on the lower extremities, and systemic 
symptoms were consistent with a diagnosis of Behçet disease. Colchicine (0.6 mg twice daily) 
a b
 Fig. 1.  a Scattered erythematous papules and pustules on the back and some papules with faint surrounding 
collarets of scale on the trunk (inset).  b Grouped clean-based ulcerations in the posterior oropharynx. 
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was initiated to treat the patient’s skin lesions and arthritis. Prednisone was also adminis-
tered to manage his ongoing odynophagia. Ophthalmology was consulted to rule out the 
possibility of occult ocular involvement and confirmed no inflammatory eye disease. Within 
24 h, the patient demonstrated improved oral symptoms and resolving cutaneous exanthem. 
Upon discharge, he was prescribed a prednisone taper and colchicine as well as follow-up 
with rheumatology.
 Discussion 
 Behçet disease is a rare rheumatologic condition first described in 1937 by its namesake 
Hulusi Behçet. Common among young adults, Behçet disease is most prevalent in individuals 
of Mediterranean, Middle-Eastern, and Far-Eastern descent  [1, 2] .
 Though it may affect nearly every organ system, Behçet disease is classically charac-
terized by recurrent orogenital ulcerations, inflammatory ocular disease, and small-vessel 
vasculitis  [3] . Neutrophilic cutaneous eruptions, arthritis, as well as gastrointestinal and 
neurologic disease may also present to varying degrees  [4] . Clinically, Behçet disease often 
presents with painful oral aphthous ulcers on the lips, cheeks, tongue, palate, or pharynx, 
essentially indistinguishable from common canker sores. However, unlike common aphthous 
ulcers, ulcerations in Behçet disease are typically larger, grouped, and take longer to heal, as 
seen in this case  [5] . With regard to distribution, the aphthous ulcers of Behçet disease typi-
cally occur on non-keratinized mucosa, which differentiates them from those of recurrent 
herpes simplex, which have a predilection for keratinized mucosa  [6] . Genital ulcers, which 
occur in 75–80% of patients, are the most specific sign  [7] . Most often found on the penile 
shaft or scrotum in men and the vulva in women, these ulcers can take weeks to months to 
heal and often scar  [7] .
 Skin eruptions, which occur in approximately 75% of patients, include acneiform lesions, 
erythema nodosum, superficial thrombophlebitis, and purpura  [4, 8, 9] . Pathergy, though not 
sensitive, is a highly specific sign of Behçet disease, as many patients develop a sterile pustule 
within 48 h of minor skin trauma, such as a needle stick  [10] . These reactions are more 
common in patients from endemic areas (50–60%) than in North American and European 
patients with Behçet disease (10–20%)  [11] . Acneiform lesions, as were seen in this patient, 
a b
 Fig. 2.  a The punch biopsy of the lower lip showed a dense inflammatory infiltrate of neutrophils, histiocytes, 
and lymphocytes (low-power view of H&E, ×100).  b Fibrinoid necrosis of the vessel walls was noted, consis-
tent with a small-vessel vasculitis (higher-power view of H&E, ×400). 
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are difficult to distinguish from the papules and pustules of ordinary acne and typically exhibit 
similar microbiologic flora  [12] .
 Although not seen in our case, ocular disease, most commonly in the form of retinal 
vasculitis, hypopyon, and anterior/posterior uveitis, affects a majority of Behçet disease 
patients  [13] . Other manifestations include central nervous system disease, renal involvement 
(i.e., secondary amyloidosis, interstitial nephritis), vascular abnormalities, and cardiac in-
volvement (i.e., pericarditis, myocarditis)  [14] .
 There are no pathognomonic diagnostic tests for Behçet disease; however, specific 
criteria exist to aid in making the diagnosis  [7] . Specifically, Behçet disease is suggested when 
a patient presents with recurrent oral aphthae, in addition to any two of the following: ocular 
pathology as described above, recurrent genital ulcers, skin lesions, or a positive pathergy 
test (papule  ≥ 2 mm developing <48 h after insertion of a 20-gauge needle 5 mm into the 
skin)  [7] .
 The histologic features of Behçet disease are nonspecific and are only confirmatory in the 
appropriate clinical context. Early lesions show superficial ulceration with associated acute 
inflammatory infiltrate. Only 50% of biopsies will reveal leukocytoclastic or lymphocytic 
vasculitis, as was seen in this patient’s histology. In addition to acneiform lesions and ulcers, 
other histopathologic features include erythema nodosum-like lesions and superficial throm-
bophlebitis  [15–17] .
 In our patient, the presence of oral and genital ulcers, a papulopustular skin eruption, 
arthritis, and shin nodules suspicious of erythema nodosum were clinically suggestive of 
Behçet disease. The corresponding histologic finding of small-vessel vasculitis was consistent 
with this diagnosis.
 Typically, Behçet disease is characterized by a relapsing-remitting course; however, it 
has been found to be more severe in young men of Middle-Eastern or Far-Eastern descent 
 [18] . The greatest causes of morbidity and mortality include neurologic disease, ocular 
involvement, and large-vessel abnormalities, which can result in gastrointestinal bleeding, 
arterial aneurysms, and Budd-Chiari syndrome, among others  [19, 20] . Despite the possibility 
of widespread disease involvement, large cohort studies have shown low mortality rates 
(0.3–5%) at median follow-up periods between 7 and 9 years  [19, 20] .
 The treatment of Behçet disease is complex given its mercurial nature, and should be 
tailored based on the individual patient’s disease severity and specific organ involvement. 
Nevertheless, given the likelihood of vital organ involvement along with the recurrent nature 
of the disease, early and aggressive treatment is of critical importance. For mucocutaneous 
lesions, topical steroids and anesthetics can be effective for isolated ulcerations, while intra-
lesional glucocorticoids can be used for larger ulcers. Topical sucralfate (1 g/5 mL 4 times 
daily) has also been found to reduce the pain and healing time of oral ulcers  [21] . Both aphthae 
and arthritis can be treated with colchicine (1–2 mg/day), nonsteroidal anti-inflammatory 
drugs, and low-dose prednisone (5–10 mg/daily) for maintenance  [22–24] . Severe or 
refractory cases of Behçet disease may require higher doses of systemic glucocorticoids. The 
treatment of other involved organ systems depends on the nature of disease presentation. 
For example, topical glucocorticoids and scopolamine are used for anterior uveitis  [25] . 
Azathioprine and systemic glucocorticoids are considered the first-line treatment for both 
posterior uveitis and neurologic manifestations, such as encephalitis and central nervous 
system vasculitis  [26–29] . When there is arterial involvement, a combination of medical and 
surgical treatments can be employed. Given the recurrent nature of the disease, a variety of 
immunomodulatory/immunosuppressive agents such as cyclosporine, methotrexate, cyclo-
phosphamide, and anti-tumor necrosis factor alpha inhibitors can be utilized for long-term 
disease maintenance  [30–35] .
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